참고문헌
- Park, S. H., and B. Rehermann. 2014. Immune responses to HCV and other hepatitis viruses. Immunity 40: 13-24. https://doi.org/10.1016/j.immuni.2013.12.010
- Chisari, F. V., M. Isogawa, and S. F. Wieland. 2010. Pathogenesis of hepatitis B virus infection. Pathol. Biol. (Paris) 58: 258-266. https://doi.org/10.1016/j.patbio.2009.11.001
- Ocama, P., C. K. Opio, and W. M. Lee. 2005. Hepatitis B virus infection: current status. Am. J. Med. 118: 1413.
- Guidotti, L. G., and F. V. Chisari. 2006. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. 1: 23-61. https://doi.org/10.1146/annurev.pathol.1.110304.100230
- Guidotti, L. G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284: 825-829. https://doi.org/10.1126/science.284.5415.825
- Thimme, R., S. Wieland, C. Steiger, J. Ghrayeb, K. A. Reimann, R. H. Purcell, and F. V. Chisari. 2003. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77: 68-76. https://doi.org/10.1128/JVI.77.1.68-76.2003
- Rehermann, B., and M. Nascimbeni. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5: 215-229. https://doi.org/10.1038/nri1573
- Maini, M. K., C. Boni, C. K. Lee, J. R. Larrubia, S. Reignat, G. S. Ogg, A. S. King, J. Herberg, R. Gilson, A. Alisa, R. Williams, D. Vergani, N. V. Naoumov, C. Ferrari, and A. Bertoletti. 2000. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191: 1269-1280. https://doi.org/10.1084/jem.191.8.1269
- Sells, M. A., M. L. Chen, and G. Acs. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. U. S. A. 84: 1005-1009. https://doi.org/10.1073/pnas.84.4.1005
- Quasdorff, M., M. Hosel, M. Odenthal, U. Zedler, F. Bohne, P. Gripon, H. P. Dienes, U. Drebber, D. Stippel, T. Goeser, and U. Protzer. 2008. A concerted action of HNF4alpha and HNF1alpha links hepatitis B virus replication to hepatocyte differentiation. Cell. Microbiol. 10: 1478-1490. https://doi.org/10.1111/j.1462-5822.2008.01141.x
- Schulze-Bergkamen, H., A. Untergasser, A. Dax, H. Vogel, P. Buchler, E. Klar, T. Lehnert, H. Friess, M. W. Buchler, M. Kirschfink, W. Stremmel, P. H. Krammer, M. Muller, and U. Protzer. 2003. Primary human hepatocytes--a valuable tool for investigation of apoptosis and hepatitis B virus infection. J. Hepatol. 38: 736-744.
- Guidotti, L. G., B. Matzke, H. Schaller, and F. V. Chisari. 1995. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69: 6158-6169.
- McMahon, B. J. 2009. The natural history of chronic hepatitis B virus infection. Hepatology 49: S45-S55. https://doi.org/10.1002/hep.22898
- Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13: 29-60. https://doi.org/10.1146/annurev.iy.13.040195.000333
- Ferrari, C., G. Missale, C. Boni, and S. Urbani. 2003. Immunopathogenesis of hepatitis B. J. Hepatol. 39 Suppl 1: S36-S42. https://doi.org/10.1016/S0168-8278(03)00137-5
- Ganem, D., and A. M. Prince. 2004. Hepatitis B virus infection--natural history and clinical consequences. N. Engl. J. Med. 350: 1118-1129. https://doi.org/10.1056/NEJMra031087
- Servet-Delprat, C., P. O. Vidalain, O. Azocar, D. F. Le, A. Fischer, and C. Rabourdin-Combe. 2000. Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus. J. Virol. 74: 4387-4393. https://doi.org/10.1128/JVI.74.9.4387-4393.2000
- Su, F., C. N. Theodosis, and R. J. Schneider. 2001. Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J. Virol. 75: 215-225. https://doi.org/10.1128/JVI.75.1.215-225.2001
- Terradillos, O., T. Pollicino, H. Lecoeur, M. Tripodi, M. L. Gougeon, P. Tiollais, and M. A. Buendia. 1998. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 17: 2115-2123. https://doi.org/10.1038/sj.onc.1202432
- Kim, K. H., and B. L. Seong. 2003. Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal. EMBO J. 22: 2104-2116. https://doi.org/10.1093/emboj/cdg210
- Miao, J., G. G. Chen, S. Y. Chun, and P. P. Lai. 2006. Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression. Cancer Lett. 236: 115-124. https://doi.org/10.1016/j.canlet.2005.05.014
- Shirakata, Y., and K. Koike. 2003. Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. J. Biol. Chem. 278: 22071-22078. https://doi.org/10.1074/jbc.M301606200
- Brenner, C., L. Galluzzi, O. Kepp, and G. Kroemer. 2013. Decoding cell death signals in liver inflammation. J. Hepatol. 59: 583-594. https://doi.org/10.1016/j.jhep.2013.03.033
- Kroemer, G., L. Galluzzi, and C. Brenner. 2007. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87: 99-163. https://doi.org/10.1152/physrev.00013.2006
- Kirby, J., K. A. Levin, and J. Inchley. 2013. Socio-environmental influences on physical activity among young people: a qualitative study. Health Educ. Res. 28: 954-969. https://doi.org/10.1093/her/cyt085
- Krtolica, A., S. Parrinello, S. Lockett, P. Y. Desprez, and J. Campisi. 2001. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. U. S. A. 98: 12072-12077. https://doi.org/10.1073/pnas.211053698
- Acs, G., M. A. Sells, R. H. Purcell, P. Price, R. Engle, M. Shapiro, and H. Popper. 1987. Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc. Natl. Acad. Sci. U. S. A. 84: 4641-4644. https://doi.org/10.1073/pnas.84.13.4641
- Diao, J., A. A. Khine, F. Sarangi, E. Hsu, C. Iorio, L. A. Tibbles, J. R. Woodgett, J. Penninger, and C. D. Richardson. 2001. X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway. J. Biol. Chem. 276: 8328-8340. https://doi.org/10.1074/jbc.M006026200
- Pan, J., L. X. Duan, B. S. Sun, and M. A. Feitelson. 2001. Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B. J. Gen. Virol. 82: 171-182. https://doi.org/10.1099/0022-1317-82-1-171
- Shih, W. L., M. L. Kuo, S. E. Chuang, A. L. Cheng, and S. L. Doong. 2000. Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 275: 25858-25864. https://doi.org/10.1074/jbc.M003578200
- Marusawa, H., S. Matsuzawa, K. Welsh, H. Zou, R. Armstrong, I. Tamm, and J. C. Reed. 2003. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J. 22: 2729-2740. https://doi.org/10.1093/emboj/cdg263
- Lee, Y. I., S. Kang-Park, S. I. Do, and Y. I. Lee. 2001. The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J. Biol. Chem. 276: 16969-16977. https://doi.org/10.1074/jbc.M011263200
- Elmore, L. W., A. R. Hancock, S. F. Chang, X. W. Wang, S. Chang, C. P. Callahan, D. A. Geller, H. Will, and C. C. Harris. 1997. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc. Natl. Acad. Sci. U. S. A. 94: 14707-14712. https://doi.org/10.1073/pnas.94.26.14707
- Huo, T. I., X. W. Wang, M. Forgues, C. G. Wu, E. A. Spillare, C. Giannini, C. Brechot, and C. C. Harris. 2001. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. Oncogene 20: 3620-3628. https://doi.org/10.1038/sj.onc.1204495
- Arzberger, S., M. Hosel, and U. Protzer. 2010. Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virus. J. Virol. 84: 11994-12001. https://doi.org/10.1128/JVI.00653-10
- Assrir, N., P. Soussan, D. Kremsdorf, and J. M. Rossignol. 2010. Role of the hepatitis B virus proteins in pro- and anti-apoptotic processes. Front. Biosci. (Landmark Ed.) 15: 12-24. https://doi.org/10.2741/3602
- Su, F., and R. J. Schneider. 1997. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc. Natl. Acad. Sci. U. S. A. 94: 8744-8749. https://doi.org/10.1073/pnas.94.16.8744
- Lindros, K. O., T. Oinonen, J. Issakainen, P. Nagy, and S. S. Thorgeirsson. 1997. Zonal distribution of transcripts of four hepatic transcription factors in the mature rat liver. Cell Biol. Toxicol. 13: 257-262. https://doi.org/10.1023/A:1007479223229
- Locaputo, S., T. L. Carrick, and J. A. Bezerra. 1999. Zonal regulation of gene expression during liver regeneration of urokinase transgenic mice. Hepatology 29: 1106-1113. https://doi.org/10.1002/hep.510290434
- Sitia, G., R. Aiolfi, L. P. Di, M. Mainetti, A. Fiocchi, F. Mingozzi, A. Esposito, Z. M. Ruggeri, F. V. Chisari, M. Iannacone, and L. G. Guidotti. 2012. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc. Natl. Acad. Sci. U. S. A. 109: E2165-E2172. https://doi.org/10.1073/pnas.1209182109
- Iannacone, M., G. Sitia, M. Isogawa, P. Marchese, M. G. Castro, P. R. Lowenstein, F. V. Chisari, Z. M. Ruggeri, and L. G. Guidotti. 2005. Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat. Med. 11: 1167-1169. https://doi.org/10.1038/nm1317
- Norris, S., C. Collins, D. G. Doherty, F. Smith, G. McEntee, O. Traynor, N. Nolan, J. Hegarty, and C. O'Farrelly. 1998. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J. Hepatol. 28: 84-90.
- Ramadori, G., and B. Saile. 2004. Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question. Gastroenterology 127: 997-1000. https://doi.org/10.1053/j.gastro.2004.07.041
- Bonorino, P., M. Ramzan, X. Camous, T. Dufeu-Duchesne, M. A. Thelu, N. Sturm, A. Dariz, C. Guillermet, M. Pernollet, J. P. Zarski, P. N. Marche, V. Leroy, and E. Jouvin-Marche. 2009. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J. Hepatol. 51: 458-467. https://doi.org/10.1016/j.jhep.2009.05.030
- Oliviero, B., S. Varchetta, E. Paudice, G. Michelone, M. Zaramella, D. Mavilio, F. F. De, S. Bruno, and M. U. Mondelli. 2009. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137: 1151-1160. https://doi.org/10.1053/j.gastro.2009.05.047
- Zhao, J., Y. Li, L. Jin, S. Zhang, R. Fan, Y. Sun, C. Zhou, Q. Shang, W. Li, Z. Zhang, and F. S. Wang. 2012. Natural killer cells are characterized by the concomitantly increased interferongamma and cytotoxicity in acute resolved hepatitis B patients. PLoS One 7: e49135. https://doi.org/10.1371/journal.pone.0049135
- Varchetta, S., D. Mele, S. Mantovani, B. Oliviero, E. Cremonesi, S. Ludovisi, G. Michelone, M. Alessiani, R. Rosati, M. Montorsi, and M. U. Mondelli. 2012. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection. Hepatology 56: 841-849. https://doi.org/10.1002/hep.25723
- Nattermann, J., G. Feldmann, G. Ahlenstiel, B. Langhans, T. Sauerbruch, and U. Spengler. 2006. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 55: 869-877. https://doi.org/10.1136/gut.2005.076463
- Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220. https://doi.org/10.1146/annurev.immunol.17.1.189
- Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4: 25-36. https://doi.org/10.1016/S1074-7613(00)80295-2
- Dunn, C., M. Brunetto, G. Reynolds, T. Christophides, P. T. Kennedy, P. Lampertico, A. Das, A. R. Lopes, P. Borrow, K. Williams, E. Humphreys, S. Afford, D. H. Adams, A. Bertoletti, and M. K. Maini. 2007. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 204: 667-680. https://doi.org/10.1084/jem.20061287
- Zhang, Z., S. Zhang, Z. Zou, J. Shi, J. Zhao, R. Fan, E. Qin, B. Li, Z. Li, X. Xu, J. Fu, J. Zhang, B. Gao, Z. Tian, and F. S. Wang. 2011. Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology 53: 73-85. https://doi.org/10.1002/hep.23977
- Arababadi, M. K., A. A. Pourfathollah, A. Jafarzadeh, and G. Hassanshahi. 2010. Serum Levels of IL-10 and IL-17A in Occult HBV-Infected South-East Iranian Patients. Hepat. Mon. 10: 31-35.
- Arababadi, M. K., A. A. Pourfathollah, A. Jafarzadeh, G. Hassanshahi, S. Daneshmandi, A. Shamsizadeh, and D. Kennedy. 2011. Non-association of IL-12 +1188 and IFN-gamma +874 polymorphisms with cytokines serum level in occult HBV infected patients. Saudi. J. Gastroenterol. 17: 30-35. https://doi.org/10.4103/1319-3767.74461
- Khorramdelazad, H., G. Hassanshahi, A. B. Nasiri, and A. M. Kazemi. 2012. High Serum Levels of TGF-beta in Iranians With Chronic HBV Infection. Hepat. Mon. 12: e7581.
- Wieland, S. F., and F. V. Chisari. 2005. Stealth and cunning: hepatitis B and hepatitis C viruses. J. Virol. 79: 9369-9380. https://doi.org/10.1128/JVI.79.15.9369-9380.2005
- Bigger, C. B., K. M. Brasky, and R. E. Lanford. 2001. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J. Virol. 75: 7059-7066. https://doi.org/10.1128/JVI.75.15.7059-7066.2001
- Su, A. I., J. P. Pezacki, L. Wodicka, A. D. Brideau, L. Supekova, R. Thimme, S. Wieland, J. Bukh, R. H. Purcell, P. G. Schultz, and F. V. Chisari. 2002. Genomic analysis of the host response to hepatitis C virus infection. Proc. Natl. Acad. Sci. U. S. A. 99: 15669-15674. https://doi.org/10.1073/pnas.202608199
- Seeger, C., and W. S. Mason. 2000. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64: 51-68. https://doi.org/10.1128/MMBR.64.1.51-68.2000
- Bertoletti, A., C. Ferrari, F. Fiaccadori, A. Penna, R. Margolskee, H. J. Schlicht, P. Fowler, S. Guilhot, and F. V. Chisari. 1991. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc. Natl. Acad. Sci. U. S. A. 88: 10445-10449. https://doi.org/10.1073/pnas.88.23.10445
- Missale, G., A. Redeker, J. Person, P. Fowler, S. Guilhot, H. J. Schlicht, C. Ferrari, and F. V. Chisari. 1993. HLA-A31- and HLAAw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177: 751-762. https://doi.org/10.1084/jem.177.3.751
- Rehermann, B., P. Fowler, J. Sidney, J. Person, A. Redeker, M. Brown, B. Moss, A. Sette, and F. V. Chisari. 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181: 1047-1058. https://doi.org/10.1084/jem.181.3.1047
- Baumert, T. F., R. Thimme, and W. F. von. 2007. Pathogenesis of hepatitis B virus infection. World J. Gastroenterol. 13: 82-90. https://doi.org/10.3748/wjg.v13.i1.82
- Wieland, S., R. Thimme, R. H. Purcell, and F. V. Chisari. 2004. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. U. S. A. 101: 6669-6674. https://doi.org/10.1073/pnas.0401771101
- Ando, K., L. G. Guidotti, S. Wirth, T. Ishikawa, G. Missale, T. Moriyama, R. D. Schreiber, H. J. Schlicht, S. N. Huang, and F. V. Chisari. 1994. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152: 3245-3253.
- Kondo, T., T. Suda, H. Fukuyama, M. Adachi, and S. Nagata. 1997. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med. 3: 409-413. https://doi.org/10.1038/nm0497-409
- Galle, P. R., W. J. Hofmann, H. Walczak, H. Schaller, G. Otto, W. Stremmel, P. H. Krammer, and L. Runkel. 1995. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182: 1223-1230. https://doi.org/10.1084/jem.182.5.1223
- Kakimi, K., T. E. Lane, S. Wieland, V. C. Asensio, I. L. Campbell, F. V. Chisari, and L. G. Guidotti. 2001. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J. Exp. Med. 194: 1755-1766. https://doi.org/10.1084/jem.194.12.1755
- Sitia, G., M. Isogawa, K. Kakimi, S. F. Wieland, F. V. Chisari, and L. G. Guidotti. 2002. Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 99: 13717-13722. https://doi.org/10.1073/pnas.172521999
- Sitia, G., M. Isogawa, M. Iannacone, I. L. Campbell, F. V. Chisari, and L. G. Guidotti. 2004. MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J. Clin. Invest. 113: 1158-1167. https://doi.org/10.1172/JCI200421087
- Iannacone, M., G. Sitia, I. Narvaiza, Z. M. Ruggeri, and L. G. Guidotti. 2007. Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus. Clin. Vaccine Immunol. 14: 1532-1535. https://doi.org/10.1128/CVI.00298-07
- Lang, P. A., C. Contaldo, P. Georgiev, A. M. El-Badry, M. Recher, M. Kurrer, L. Cervantes-Barragan, B. Ludewig, T. Calzascia, B. Bolinger, D. Merkler, B. Odermatt, M. Bader, R. Graf, P. A. Clavien, A. N. Hegazy, M. Lohning, N. L. Harris, P. S. Ohashi, H. Hengartner, R. M. Zinkernagel, and K. S. Lang. 2008. Aggravation of viral hepatitis by platelet-derived serotonin. Nat. Med. 14: 756-761. https://doi.org/10.1038/nm1780
- Tsui, L. V., L. G. Guidotti, T. Ishikawa, and F. V. Chisari. 1995. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 92: 12398-12402. https://doi.org/10.1073/pnas.92.26.12398
- Urbani, S., C. Boni, B. Amadei, P. Fisicaro, S. Cerioni, M. A. Valli, G. Missale, and C. Ferrari. 2005. Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection. Hepatology 41: 826-831. https://doi.org/10.1002/hep.20614
- Barnaba, V., A. Franco, A. Alberti, C. Balsano, R. Benvenuto, and F. Balsano. 1989. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J. Immunol. 143: 2650-2655.
- Burton, D. R., R. A. Williamson, and P. W. Parren. 2000. Antibody and virus: binding and neutralization. Virology 270: 1-3. https://doi.org/10.1006/viro.2000.0239
- Schilling, R., S. Ijaz, M. Davidoff, J. Y. Lee, S. Locarnini, R. Williams, and N. V. Naoumov. 2003. Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions. J. Virol. 77: 8882-8892. https://doi.org/10.1128/JVI.77.16.8882-8892.2003
- Rehermann, B., C. Ferrari, C. Pasquinelli, and F. V. Chisari. 1996. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat. Med. 2: 1104-1108. https://doi.org/10.1038/nm1096-1104
- Moss, B., G. L. Smith, J. L. Gerin, and R. H. Purcell. 1984. Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature 311: 67-69. https://doi.org/10.1038/311067a0
- Shouval, D., and D. Samuel. 2000. Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review. Hepatology 32: 1189-1195. https://doi.org/10.1053/jhep.2000.19789
- Cooper, N. R. and G. R. Nemerow. 1983. Complement, viruses, and virus-infected cells. Springer Semin. Immunopathol. 6: 327-347. https://doi.org/10.1007/BF02116278
피인용 문헌
- Multiplex qPCR for serodetection and serotyping of hepatitis viruses: A brief review vol.22, pp.20, 2015, https://doi.org/10.3748/wjg.v22.i20.4824
- Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure vol.90, pp.23, 2015, https://doi.org/10.1128/jvi.01473-16
- Apigenin inhibits D-galactosamine/LPS-induced liver injury through upregulation of hepatic Nrf-2 and PPARγ expressions in mice vol.493, pp.1, 2015, https://doi.org/10.1016/j.bbrc.2017.08.141
- Detection of Necroptosis in Ligand-Mediated and Hypoxia-Induced Injury of Hepatocytes Using a Novel Optic Probe-Detecting Receptor-Interacting Protein (RIP)1/RIP3 Binding vol.26, pp.3, 2015, https://doi.org/10.3727/096504017x15005102445191
- Therapeutic effects of mesenchymal stem cells combined with short hairpin RNA on liver injury induced by hepatitis B virus infection vol.17, pp.1, 2015, https://doi.org/10.3892/mmr.2017.8096
- Identification of serum β-catenin as a biomarker in patients with HBV-related liver diseases vol.16, pp.None, 2018, https://doi.org/10.1186/s12967-018-1645-x
- Association between IL-37 gene polymorphisms and risk of HBV-related liver disease in a Saudi Arabian population vol.9, pp.None, 2015, https://doi.org/10.1038/s41598-019-42808-4
- Mechanism of KLF4 Protection against Acute Liver Injury via Inhibition of Apelin Signaling vol.2019, pp.None, 2015, https://doi.org/10.1155/2019/6140360
- Total flavonoids from Tetrastigma hemsleyanum ameliorates inflammatory stress in concanavalin A-induced autoimmune hepatitis mice by regulating Treg/Th17 immune homeostasis vol.27, pp.6, 2019, https://doi.org/10.1007/s10787-019-00599-0
- Protective effect of apigenin on d-galactosamine/LPS-induced hepatocellular injury by increment of Nrf-2 nucleus translocation vol.393, pp.6, 2015, https://doi.org/10.1007/s00210-019-01760-w
- Loss of hepatocyte cell division leads to liver inflammation and fibrosis vol.16, pp.11, 2015, https://doi.org/10.1371/journal.pgen.1009084
- Analysis of a stochastic HBV infection model with delayed immune response vol.18, pp.5, 2015, https://doi.org/10.3934/mbe.2021264
- Distinct Hepatitis B and HIV co‐infected populations in Canada vol.28, pp.3, 2015, https://doi.org/10.1111/jvh.13453
- Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression vol.22, pp.11, 2015, https://doi.org/10.3390/ijms22115497
- Comparative expression of pro-inflammatory and apoptotic biosignatures in chronic HBV-infected patients with and without liver cirrhosis vol.161, pp.no.pa, 2015, https://doi.org/10.1016/j.micpath.2021.105231
- A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus vol.11, pp.1, 2015, https://doi.org/10.1038/s41598-021-91196-1